Skip to main content

Deferred Prosecution Agreements | Prosecution Agreements

Deferred Prosecution Agreements | Prosecution Agreements: Deferred Prosecution Agreements

Federal Organizational Prosecution Agreements

Description

This library collection contains scanned federal organizational prosecution agreements. It is intended to provide a resource for research concerning federal prosecution of organizations. The website was created by Professor Brandon Garrett (bgarrett@virginia.edu) and Jon Ashley (jaa6c@virginia.edu) and will be periodically updated to reflect additional agreements or other developments. We welcome any inquiries or feedback, including questions, corrections or suggestions for additional material to be added to the collection. The agreements, as indicated below, may be displayed by name of entity, jurisdiction or date. Additional information concerning organizational prosecution agreements is in a 2007 Virginia Law Review article. A more detailed version of the list below can be found in this Excel spreadsheet (last updated 6/7/2011). Please cite to this resource collection as: Brandon L. Garrett and Jon Ashley, Federal Organizational Prosecution Agreements, University of Virginia School of Law, at http://lib.law.virginia.edu/Garrett/prosecution_agreements/home.suphp.

Please note that we are currently updating the infrastructure for this site to better support search and sort capabilities. The new iteration of the site will include both corporate plea and prosecution agreements and will contain substantially more data for researchers and practitioners. In the meantime if there are particular features you would like to see incorporated drop us a line at: jaa6c@virginia.edu

The dockets below are unofficial and may be incomplete or out-of-date. The official docket is available on PACER (fees may apply).

Popular posts from this blog

Elizabeth Holmes Discusses Theranos at WSJDLive 2015

Elizabeth Holmes Discusses Theranos at WSJDLive 2015 Elizabeth Holmes Discusses Theranos at WSJDLive 2015 At the WSJDLive 2015 conference, Theranos founder and CEO Elizabeth Holmes discusses her company's proprietary technologies, the FDA's inspection of its facilities, and the assertion that her company was too quick to market its products.